Sumitomo Dainippon Pharma Co., Ltd.:企業の戦略・SWOT・財務分析

MarketLineが発行した調査報告書(SWOT20MY4267)
◆英語タイトル:Sumitomo Dainippon Pharma Co., Ltd. - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY4267
◆発行会社(リサーチ会社):MarketLine
◆発行日:2020年2月
◆ページ数:48
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:日本
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。MarketLine社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Sumitomo Dainippon Pharma Co., Ltd. – Strategy, SWOT and Corporate Finance Report
Summary

Sumitomo Dainippon Pharma Co., Ltd. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Sumitomo Dainippon Pharma Co Ltd (SDP or ‘the company’) is a Japan-based developer, manufacturer, and importer of global pharmaceutical products. The company focuses on major therapeutic areas which include cardiovascular, central nervous system (CNS), diabetes, respiratory psychiatry, oncology and neurology and infectious diseases. It also offers research materials, chemical product materials, food additives, veterinary products, food ingredients, cosmetic materials, diagnostic agents, and other products. SDP owns and operates manufacturing and distribution facilities; and research laboratories across Japan. SDP primarily operates in Asia, North America and Europe. The company is headquartered in Chuo-Ku, Osaka, Japan.

Scope

- Detailed information on Sumitomo Dainippon Pharma Co., Ltd. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Sumitomo Dainippon Pharma Co., Ltd. in the form of a SWOT analysis
- An in-depth view of the business model of Sumitomo Dainippon Pharma Co., Ltd. including a breakdown and examination of key business segments
- Intelligence on Sumitomo Dainippon Pharma Co., Ltd.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Sumitomo Dainippon Pharma Co., Ltd., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Sumitomo Dainippon Pharma Co., Ltd. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Sumitomo Dainippon Pharma Co., Ltd. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Sumitomo Dainippon Pharma Co., Ltd.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Sumitomo Dainippon Pharma Co., Ltd.: Company Overview
Sumitomo Dainippon Pharma Co., Ltd.: Overview and Key Facts
Sumitomo Dainippon Pharma Co., Ltd.: Overview
Sumitomo Dainippon Pharma Co., Ltd.: Key Facts
Sumitomo Dainippon Pharma Co., Ltd.: Key Employees
Sumitomo Dainippon Pharma Co., Ltd.: Key Employee Biographies
Sumitomo Dainippon Pharma Co., Ltd.: Major Products and Services
Sumitomo Dainippon Pharma Co., Ltd.: Company History
Sumitomo Dainippon Pharma Co., Ltd.: Management Statement
Sumitomo Dainippon Pharma Co., Ltd.: Locations and Subsidiaries
Sumitomo Dainippon Pharma Co., Ltd.: Key Competitors
Sumitomo Dainippon Pharma Co., Ltd.: Company Analysis
Sumitomo Dainippon Pharma Co., Ltd.: Business Description
Sumitomo Dainippon Pharma Co., Ltd.: SWOT Analysis
Sumitomo Dainippon Pharma Co., Ltd.: SWOT Overview
Sumitomo Dainippon Pharma Co., Ltd.: Strengths
Sumitomo Dainippon Pharma Co., Ltd.: Weaknesses
Sumitomo Dainippon Pharma Co., Ltd.: Opportunities
Sumitomo Dainippon Pharma Co., Ltd.: Threats
Sumitomo Dainippon Pharma Co., Ltd.: Corporate Financial Deals Activity
Sumitomo Dainippon Pharma Co., Ltd.: Financial Deals Overview
Sumitomo Dainippon Pharma Co., Ltd.: Targets and Partners
Sumitomo Dainippon Pharma Co., Ltd.: Top Deals 2016 – 2020YTD*
Sumitomo Dainippon Pharma Co., Ltd.: Advisors
Sumitomo Dainippon Pharma Co., Ltd.: Top Legal Advisors
Sumitomo Dainippon Pharma Co., Ltd.: Top Financial Advisors
Sumitomo Dainippon Pharma Co., Ltd.: Mergers and Acquisitions
Sumitomo Dainippon Pharma Co., Ltd.: Corporate Venturing
Sumitomo Dainippon Pharma Co., Ltd.: Partnership
Sumitomo Dainippon Pharma Co., Ltd.: Recent Developments
Sumitomo Dainippon Pharma Co., Ltd.: News and Events Summary
Sumitomo Dainippon Pharma Co., Ltd.: Business Expansion
Sumitomo Dainippon Pharma Co., Ltd.: Contracts
Sumitomo Dainippon Pharma Co., Ltd.: Corporate Governance
Sumitomo Dainippon Pharma Co., Ltd.: Financial Deals
Sumitomo Dainippon Pharma Co., Ltd.: Market Developments
Sumitomo Dainippon Pharma Co., Ltd.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Sumitomo Dainippon Pharma Co., Ltd.: Key Facts
Table 2: Sumitomo Dainippon Pharma Co., Ltd.: Key Employees
Table 3: Sumitomo Dainippon Pharma Co., Ltd.: Company History
Table 4: Sumitomo Dainippon Pharma Co., Ltd.: Locations and Subsidiaries
Table 5: Sumitomo Dainippon Pharma Co., Ltd.: Key Competitors
Table 6: Sumitomo Dainippon Pharma Co., Ltd.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Sumitomo Dainippon Pharma Co., Ltd.: M&A Activity by Geography (TTM*)
Table 8: Sumitomo Dainippon Pharma Co., Ltd.: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 9: Sumitomo Dainippon Pharma Co., Ltd.: M&A Average Deal Size - Value (US$m)
Table 10: Sumitomo Dainippon Pharma Co., Ltd.: Targets and Partners
Table 11: Sumitomo Dainippon Pharma Co., Ltd.: Top Deals 2016 - 2020YTD*
Table 12: Sumitomo Dainippon Pharma Co., Ltd.: Legal Advisor Ranking by Value (US$m)
Table 13: Sumitomo Dainippon Pharma Co., Ltd.: Financial Advisor Ranking by Value (US$m)
Table 14: Sumitomo Dainippon Pharma Co., Ltd.: M&A Volume and Value Trend (2016 - YTD*2020)
Table 15: Sumitomo Dainippon Pharma Co., Ltd.: M&A Activity by Geography (2016 - YTD*2020)
Table 16: Sumitomo Dainippon Pharma Co., Ltd.: Corporate Venturing Volume and Value Trend (2016 - YTD*2020)
Table 17: Sumitomo Dainippon Pharma Co., Ltd.: Corporate Venturing by Geography (2016 - YTD*2020)
Table 18: Sumitomo Dainippon Pharma Co., Ltd.: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 19: Sumitomo Dainippon Pharma Co., Ltd.: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 20: Sumitomo Dainippon Pharma Co., Ltd.: News and Events Summary
Table 21: Sumitomo Dainippon Pharma Co., Ltd.: Business Expansion
Table 22: Sumitomo Dainippon Pharma Co., Ltd.: Contracts
Table 23: Sumitomo Dainippon Pharma Co., Ltd.: Corporate Governance
Table 24: Sumitomo Dainippon Pharma Co., Ltd.: Financial Deals
Table 25: Sumitomo Dainippon Pharma Co., Ltd.: Market Developments
Table 26: Sumitomo Dainippon Pharma Co., Ltd.: Strategy and Operations

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Sumitomo Dainippon Pharma Co., Ltd.:企業の戦略・SWOT・財務分析(Sumitomo Dainippon Pharma Co., Ltd. - Strategy, SWOT and Corporate Finance Report)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆